Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats

Yoichi Kawasaki, Hiroaki Araki, Katsuya Suemaru, Yoshihisa Kitamura, Yutaka Gomita, Toshiaki Sendo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A better understanding of the neurochemical mechanisms mediating the aversive consequences of drug withdrawal is important for understanding drug addiction. We previously demonstrated that the inhibitory effect of glutamate receptor antagonists on the conditioned place aversion (CPA) induced by naloxone-precipitated withdrawal after a single morphine exposure could be blocked by dopamine receptor antagonists. Thus, a glutamatergic-dopaminergic interaction may participate in this phenomenon. The current study was undertaken to further characterize this interaction by employing both D 1 (SCH 23390) and D 2 (raclopride and eticlopride) dopamine receptor antagonists. The influence of these antagonists on the attenuation of CPA by MK-801 (NMDA receptor antagonist), GYKI 52466 (AMPA receptor antagonist), and MCPG (metabotropic glutamate receptor antagonist) was determined in rats receiving a single dose of morphine. The dopamine antagonists showed either a significant reversal or a tendency to reverse the effects of MK-801 on CPA. The effect of GYKI 52466 was also attenuated by the blockade of either D 1 or D 2 receptors. The effect of MCPG, however, was only blocked by D 2 antagonists and not by the D 1 antagonist SCH 23390. These results add evidence to the hypothesis that a glutamatergic-dopaminergic interaction may be involved in the CPA induced by naloxone-precipitated withdrawal following a single morphine exposure and suggest that both D 1 and D 2 dopamine receptor signaling mechanisms play a role in mediating the aversive aspects of acute dependence.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalJournal of Pharmacological Sciences
Volume117
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Dopamine Antagonists
Naloxone
Morphine
Excitatory Amino Acid Antagonists
eticlopride
Dizocilpine Maleate
Raclopride
Metabotropic Glutamate Receptors
AMPA Receptors
Dopamine Receptors
N-Methyl-D-Aspartate Receptors
Substance-Related Disorders
Pharmaceutical Preparations
GYKI 52466
SCH 23390

Keywords

  • Acute dependence
  • Conditioned place aversion
  • Dopaminergic
  • Glutamatergic
  • Morphine

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

@article{d001b10b126048d9ac2cb515b40ad069,
title = "Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats",
abstract = "A better understanding of the neurochemical mechanisms mediating the aversive consequences of drug withdrawal is important for understanding drug addiction. We previously demonstrated that the inhibitory effect of glutamate receptor antagonists on the conditioned place aversion (CPA) induced by naloxone-precipitated withdrawal after a single morphine exposure could be blocked by dopamine receptor antagonists. Thus, a glutamatergic-dopaminergic interaction may participate in this phenomenon. The current study was undertaken to further characterize this interaction by employing both D 1 (SCH 23390) and D 2 (raclopride and eticlopride) dopamine receptor antagonists. The influence of these antagonists on the attenuation of CPA by MK-801 (NMDA receptor antagonist), GYKI 52466 (AMPA receptor antagonist), and MCPG (metabotropic glutamate receptor antagonist) was determined in rats receiving a single dose of morphine. The dopamine antagonists showed either a significant reversal or a tendency to reverse the effects of MK-801 on CPA. The effect of GYKI 52466 was also attenuated by the blockade of either D 1 or D 2 receptors. The effect of MCPG, however, was only blocked by D 2 antagonists and not by the D 1 antagonist SCH 23390. These results add evidence to the hypothesis that a glutamatergic-dopaminergic interaction may be involved in the CPA induced by naloxone-precipitated withdrawal following a single morphine exposure and suggest that both D 1 and D 2 dopamine receptor signaling mechanisms play a role in mediating the aversive aspects of acute dependence.",
keywords = "Acute dependence, Conditioned place aversion, Dopaminergic, Glutamatergic, Morphine",
author = "Yoichi Kawasaki and Hiroaki Araki and Katsuya Suemaru and Yoshihisa Kitamura and Yutaka Gomita and Toshiaki Sendo",
year = "2011",
doi = "10.1254/jphs.10230FP",
language = "English",
volume = "117",
pages = "27--33",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8648",
publisher = "The Japanese Pharmacological Society",
number = "1",

}

TY - JOUR

T1 - Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats

AU - Kawasaki, Yoichi

AU - Araki, Hiroaki

AU - Suemaru, Katsuya

AU - Kitamura, Yoshihisa

AU - Gomita, Yutaka

AU - Sendo, Toshiaki

PY - 2011

Y1 - 2011

N2 - A better understanding of the neurochemical mechanisms mediating the aversive consequences of drug withdrawal is important for understanding drug addiction. We previously demonstrated that the inhibitory effect of glutamate receptor antagonists on the conditioned place aversion (CPA) induced by naloxone-precipitated withdrawal after a single morphine exposure could be blocked by dopamine receptor antagonists. Thus, a glutamatergic-dopaminergic interaction may participate in this phenomenon. The current study was undertaken to further characterize this interaction by employing both D 1 (SCH 23390) and D 2 (raclopride and eticlopride) dopamine receptor antagonists. The influence of these antagonists on the attenuation of CPA by MK-801 (NMDA receptor antagonist), GYKI 52466 (AMPA receptor antagonist), and MCPG (metabotropic glutamate receptor antagonist) was determined in rats receiving a single dose of morphine. The dopamine antagonists showed either a significant reversal or a tendency to reverse the effects of MK-801 on CPA. The effect of GYKI 52466 was also attenuated by the blockade of either D 1 or D 2 receptors. The effect of MCPG, however, was only blocked by D 2 antagonists and not by the D 1 antagonist SCH 23390. These results add evidence to the hypothesis that a glutamatergic-dopaminergic interaction may be involved in the CPA induced by naloxone-precipitated withdrawal following a single morphine exposure and suggest that both D 1 and D 2 dopamine receptor signaling mechanisms play a role in mediating the aversive aspects of acute dependence.

AB - A better understanding of the neurochemical mechanisms mediating the aversive consequences of drug withdrawal is important for understanding drug addiction. We previously demonstrated that the inhibitory effect of glutamate receptor antagonists on the conditioned place aversion (CPA) induced by naloxone-precipitated withdrawal after a single morphine exposure could be blocked by dopamine receptor antagonists. Thus, a glutamatergic-dopaminergic interaction may participate in this phenomenon. The current study was undertaken to further characterize this interaction by employing both D 1 (SCH 23390) and D 2 (raclopride and eticlopride) dopamine receptor antagonists. The influence of these antagonists on the attenuation of CPA by MK-801 (NMDA receptor antagonist), GYKI 52466 (AMPA receptor antagonist), and MCPG (metabotropic glutamate receptor antagonist) was determined in rats receiving a single dose of morphine. The dopamine antagonists showed either a significant reversal or a tendency to reverse the effects of MK-801 on CPA. The effect of GYKI 52466 was also attenuated by the blockade of either D 1 or D 2 receptors. The effect of MCPG, however, was only blocked by D 2 antagonists and not by the D 1 antagonist SCH 23390. These results add evidence to the hypothesis that a glutamatergic-dopaminergic interaction may be involved in the CPA induced by naloxone-precipitated withdrawal following a single morphine exposure and suggest that both D 1 and D 2 dopamine receptor signaling mechanisms play a role in mediating the aversive aspects of acute dependence.

KW - Acute dependence

KW - Conditioned place aversion

KW - Dopaminergic

KW - Glutamatergic

KW - Morphine

UR - http://www.scopus.com/inward/record.url?scp=80052899251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052899251&partnerID=8YFLogxK

U2 - 10.1254/jphs.10230FP

DO - 10.1254/jphs.10230FP

M3 - Article

VL - 117

SP - 27

EP - 33

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8648

IS - 1

ER -